FindMyKOL
Clinical trialNCT02332772UnknownObservational

Prospective Study of Colonoscopic Resection of Large Polyps and Flat Lesions

NCT02332772 is an observational study sponsored by M.D. Anderson Cancer Center. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Colon Polyps. The registry lists an enrollment of 10,000 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2015 and a primary completion date of 30 Apr 2025.

SponsorM.D. Anderson Cancer CenterEnrollment10,000Colon Polyps
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02332772
FieldValue
Registry IDNCT02332772
StatusUnknown
Study typeObservational study
Lead sponsorM.D. Anderson Cancer Center
Enrollment10,000
Registered sites1
Countries1
ConditionsColon Polyps
Start30 Apr 2015
Primary completion30 Apr 2025
Study completion30 Apr 2025
Last update posted13 May 2019

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

With this study, the investigators plan to review the performance of colonoscopic resection of large (\> 1 cm) and flat lesions in the colon. The findings will help us define the role of colonoscopic resection of colon polyps and flat lesions and identity areas for improvement. The data will be used for continuing quality improvement and presenting our outcomes at academic meetings and publishing our results in peer reviewed journals.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site, 1 recruiting
  • University of Texas Md Anderson Cancer Center

    Houston

    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 site, 1 recruitingTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02332772

Each answer restates registry values shown on this page.

What is NCT02332772?

NCT02332772 is an observational study sponsored by M.D. Anderson Cancer Center. It studies Colon Polyps.

Who leads NCT02332772?

The registry names Gottumukkala S. Raju, MD (principal investigator, M.D. Anderson Cancer Center) as the overall official.

Where does NCT02332772 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT02332772 expected to complete?

The registry lists a primary completion date of 30 Apr 2025 and a study completion date of 30 Apr 2025. The sponsor last updated the record on 13 May 2019.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.